In Memoriam

In memoriam: Michael Gottlieb

ASBMB Today Staff
July 25, 2022

Michael Gottlieb, a global health researcher and a member of the American Society for Biochemistry and Molecular Biology since 1989, died April 27, 2021, the ASBMB learned recently. He was 76 and had cancer.

Michael Gottlieb

Born Oct. 18, 1944, Gottlieb earned his Ph.D. in biology from the City University of New York. He conducted postdoctoral research in the bacterial physiology unit of the Harvard Medical School and in the Laboratory of Parasitic Diseases at the National Institute of Allergy and Infectious Diseases. He joined the faculty of the Johns Hopkins University School of Hygiene and Public Health in 1978, where his research focused on the biochemistry and cell biology of pathogenic trypanosomatid protozoa, which cause African sleeping sickness and other plant and animal diseases.

In 1991, Gottlieb returned to the NIAID as program officer in the Parasitology and International Programs Branch of the Division of Microbiology and Infectious Diseases. A decade later, he was named chief of the branch. He managed NIAID grants on parasite biology, coordinated the institute’s network of international centers for tropical disease research and represented the institute in its support of the Multilateral Initiative on Malaria. He initiated the NIAID pathogen genomics research program and helped create an environment and translational research program that accelerated development of molecular diagnostics and therapeutic interventions for parasitic diseases. 

Gottlieb retired from the NIAID in 2004 and joined the Foundation for the National Institutes of Health as associate director for science. As a founding member of the Grand Challenges in Global Health team at FNIH, he worked with the Bill & Melinda Gates Foundation, Wellcome and the Canadian Institutes of Health, overseeing projects on drug discovery, genomics and discovery of new insecticides and repellents. He was principal investigator of the multinational Malnutrition and Enteric Disease Study, which focused on child health and development. He retired from FNIH in 2018 and moved to Manhattan to focus his time on family and community activities.

In addition to the ASBMB, Gottlieb was a longtime member of the American Society of Tropical Medicine and Hygiene and an ASTMH councilor from 1996 to 2000. An ASTMH memorial noted that he would be remembered for the wisdom, kindness, helpfulness and generosity of spirit he brought to every facet of his work.” 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.